RECRUITING

HER2-positive Breast Cancer Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Official Title

Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)

Quick Facts

Study Start:2024-09-27
Study Completion:2044-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06603597

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Stage I-IV HER2-positive breast cancer
  1. * None

Contacts and Locations

Study Contact

Study Coordinator
CONTACT
913-588-6079
PRO-HER2@kumc.edu

Study Locations (Sites)

KUCC - Indian Creek
Overland Park, Kansas, 66211
United States
KCCC Overland Park
Overland Park, Kansas, 66215
United States
The University of Kansas Cancer Center
Westwood, Kansas, 66205
United States
KUCC - North
Kansas City, Missouri, 64154
United States
KUCC - Lee's Summit
Lee's Summit, Missouri, 64064
United States

Collaborators and Investigators

Sponsor: Priyanka Sharma

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-27
Study Completion Date2044-10

Study Record Updates

Study Start Date2024-09-27
Study Completion Date2044-10

Terms related to this study

Keywords Provided by Researchers

  • breast cancer
  • registry
  • HER2+
  • HER2 positive

Additional Relevant MeSH Terms

  • HER2 + Breast Cancer